Chinese english Germany Japanese Korea

BRD0705

BRD0705 Struktur
2056261-41-5
CAS-Nr.
2056261-41-5
Englisch Name:
BRD0705
Synonyma:
BRD0705;BRD0705 (BRD-0705;5H-Pyrazolo[3,4-b]quinolin-5-one, 4-ethyl-1,2,4,6,7,8-hexahydro-7,7-dimethyl-4-phenyl-, (4S)-;β-catenin,Glycogen synthase kinase 3,leukemia,Acute,survival,BRD-0705,inhibit,Inhibitor,oral,BRD0705,myeloid,Glycogen synthase kinase-3,bioavailability,BRD 0705,GSK-3,kinase
CBNumber:
CB24667681
Summenformel:
C20H23N3O
Molgewicht:
321.42
MOL-Datei:
2056261-41-5.mol
Request For Quotation

BRD0705 Eigenschaften

Siedepunkt:
512.0±50.0 °C(Predicted)
Dichte
1.22±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMSO: 300 mg/mL (933.36 mM)
Aggregatzustand
Solid
pka
14.82±0.60(Predicted)
Farbe
White to light yellow

Sicherheit

BRD0705 Chemische Eigenschaften,Einsatz,Produktion Methoden

BRD0705 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

BRD0705 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 31)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
Wuhan Topule Biopharmaceutical Co., Ltd 		+8618327326525
 masar@topule.com China 8474 58
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 52927 58
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185
 sales-cpd@caerulumpharma.com China 3466 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696，15000506266 15000506266
 China 4362 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
 info@efebio.com China 9806 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994
 2853530910@QQ.com China 8014 62
Shanghai Rechem science Co., Ltd. 21-31433387 15618786686
 sales@rechemscience.com China 2976 58
DC Chemicals 021-58447131 13564518121
 sales@dcchemicals.com China 9412 58
Changzhou Chenhong Biotechnology Co., Ltd. 0519-85788828 13775037613
 sales@chemrenpharm.com China 3600 58
  • BRD0705 (BRD-0705
  • BRD0705
  • β-catenin,Glycogen synthase kinase 3,leukemia,Acute,survival,BRD-0705,inhibit,Inhibitor,oral,BRD0705,myeloid,Glycogen synthase kinase-3,bioavailability,BRD 0705,GSK-3,kinase
  • 5H-Pyrazolo[3,4-b]quinolin-5-one, 4-ethyl-1,2,4,6,7,8-hexahydro-7,7-dimethyl-4-phenyl-, (4S)-
  • 2056261-41-5
Copyright 2019 © ChemicalBook. All rights reserved